728 related articles for article (PubMed ID: 30671023)
1. Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble?
Moutinho-Ribeiro P; Macedo G; Melo SA
Front Endocrinol (Lausanne); 2018; 9():779. PubMed ID: 30671023
[TBL] [Abstract][Full Text] [Related]
2. Progress of Exosomes in the Diagnosis and Treatment of Pancreatic Cancer.
Wu H; Chen X; Ji J; Zhou R; Liu J; Ni W; Qu L; Ni H; Ni R; Bao B; Xiao M
Genet Test Mol Biomarkers; 2019 Mar; 23(3):215-222. PubMed ID: 30793953
[TBL] [Abstract][Full Text] [Related]
3. Exosome-based liquid biopsies in cancer: opportunities and challenges.
Yu W; Hurley J; Roberts D; Chakrabortty SK; Enderle D; Noerholm M; Breakefield XO; Skog JK
Ann Oncol; 2021 Apr; 32(4):466-477. PubMed ID: 33548389
[TBL] [Abstract][Full Text] [Related]
4. Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression.
Nuzhat Z; Kinhal V; Sharma S; Rice GE; Joshi V; Salomon C
Oncotarget; 2017 Mar; 8(10):17279-17291. PubMed ID: 27999198
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
[TBL] [Abstract][Full Text] [Related]
6. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
7. Exosomes as Pleiotropic Players in Pancreatic Cancer.
De Lellis L; Florio R; Di Bella MC; Brocco D; Guidotti F; Tinari N; Grassadonia A; Lattanzio R; Cama A; Veschi S
Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33803470
[TBL] [Abstract][Full Text] [Related]
8. Exosomal proteins as potential markers of tumor diagnosis.
Li A; Zhang T; Zheng M; Liu Y; Chen Z
J Hematol Oncol; 2017 Dec; 10(1):175. PubMed ID: 29282096
[TBL] [Abstract][Full Text] [Related]
9. Plasma-Derived Exosomal ALIX as a Novel Biomarker for Diagnosis and Classification of Pancreatic Cancer.
Yang J; Zhang Y; Gao X; Yuan Y; Zhao J; Zhou S; Wang H; Wang L; Xu G; Li X; Wang P; Zou X; Zhu D; Lv Y; Zhang S
Front Oncol; 2021; 11():628346. PubMed ID: 34026608
[TBL] [Abstract][Full Text] [Related]
10. Exosomes: proteomic insights and diagnostic potential.
Simpson RJ; Lim JW; Moritz RL; Mathivanan S
Expert Rev Proteomics; 2009 Jun; 6(3):267-83. PubMed ID: 19489699
[TBL] [Abstract][Full Text] [Related]
11. A Snapshot of The Tumor Microenvironment in Colorectal Cancer: The Liquid Biopsy.
Herrera M; Galindo-Pumariño C; García-Barberán V; Peña C
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795332
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
[TBL] [Abstract][Full Text] [Related]
14. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
[TBL] [Abstract][Full Text] [Related]
15. Exosome mediated communication within the tumor microenvironment.
Milane L; Singh A; Mattheolabakis G; Suresh M; Amiji MM
J Control Release; 2015 Dec; 219():278-294. PubMed ID: 26143224
[TBL] [Abstract][Full Text] [Related]
16. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.
Nedaeinia R; Manian M; Jazayeri MH; Ranjbar M; Salehi R; Sharifi M; Mohaghegh F; Goli M; Jahednia SH; Avan A; Ghayour-Mobarhan M
Cancer Gene Ther; 2017 Feb; 24(2):48-56. PubMed ID: 27982021
[TBL] [Abstract][Full Text] [Related]
17. Salivary exosomes as potential biomarkers in cancer.
Nair S; Tang KD; Kenny L; Punyadeera C
Oral Oncol; 2018 Sep; 84():31-40. PubMed ID: 30115473
[TBL] [Abstract][Full Text] [Related]
18. The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer.
Schwarzenbach H
Expert Rev Mol Diagn; 2015; 15(9):1159-69. PubMed ID: 26202667
[TBL] [Abstract][Full Text] [Related]
19. [Exosomal microRNAs as a part of the cell-cell communication in cancer].
Wesołowska A; Piwocka K
Postepy Biochem; 2017; 63(2):110-118. PubMed ID: 28689377
[TBL] [Abstract][Full Text] [Related]
20. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
